News

“Customized Schizophrenia Treatment”: Benefits of Therapeutic Innovations in Inpatient and Outpatient Care Thanks to Gentler Antipsychotics

24. 5. 2023 Source: Modern Treatment of Schizophrenia

In the field of schizophrenia treatment, the possibility of significantly greater individualization, brought about by gentler antipsychotics, is currently a hot topic. A major focus is the differences in schizophrenia therapy during hospitalization and subsequently in outpatient care. These topics were also addressed in a seminar called “Customized Schizophrenia Treatment,” supported by Angelini, which took place in Brno.

Angiodysplasia as a Serious Problem in Patients with von Willebrand Disease −⁠ Case Study

Bleeding into the gastrointestinal tract can become a very significant cause of morbidity and mortality in patients with von Willebrand disease (vWD). It has been described that gastrointestinal (GI)...

19. 5. 2023 Source: Von Willebrand Disease

Pharmacotherapy of Glaucoma in a Nutshell According to the Latest Recommendations of the European Glaucoma Society

The European Glaucoma Society published its latest, 5th version of recommendations for the treatment of glaucoma in 2021. The following text, based on these recommendations, focuses in a nutshell on the...

18. 5. 2023 Source: Treatment of Glaucoma

Model of Risk of Bleeding Associated with Physical Activity in Hemophiliacs with Factor and Non-Factor Treatment

In the treatment of hemophilia A, both FVIII concentrate replacement therapy and non-factor therapy are available today. However, there is no clinical data comparing the risk of bleeding associated…

18. 5. 2023 Source: Hemophilia

When to Consider Gaucher Disease and How to Diagnose It Early and Correctly

Considering Gaucher disease (GD) as a cause of a patient's problems, especially in the case of splenomegaly and bleeding manifestations, is very important, regardless of age. Screening using the dry…

16. 5. 2023 Source: Rare Diseases in Hematology

COMMENTARY FROM PRACTICE: On Some Aspects of Care for Patients with Parkinson's Disease

What issues do we still encounter in the diagnosis and treatment of Parkinson's disease even today, despite medical advancements? How to fine-tune the management of care for these patients, facilitate...

15. 5. 2023 Source: Parkinson's Disease

Detection of ceftazidime/avibactam-resistant Enterobacteriaceae strains using a new rapid test

Ceftazidime/avibactam (CZA) is a relatively new antibiotic with very good efficacy against carbapenem-resistant Enterobacteriaceae. Unfortunately, strains resistant to this antimicrobial treatment…

15. 5. 2023 Source: Anti-Infectives

Diagnosing Myelodysplastic Syndrome According to MDS Europe

In 2021, the European Hematology Association (EHA) endorsed the recommendations of the MDS Europe group for the diagnosis of myelodysplastic syndrome (MDS). MDS-RIGHT is a large European project…

15. 5. 2023 Source: medScope.pro

Proton Therapy and Its Results in the Treatment of Bilateral Breast Cancer

Breast cancer is the most common malignant tumor disease in women, and its incidence sharply increases after the age of 50. Although its incidence shows a continuously increasing trend, the…

11. 5. 2023 Source: Proton Radiotherapy

Compression Therapy with Zinc Oxide Dressings in Dermatology

Zinc oxide dressings have a long-standing tradition and continue to find their place in modern dermatology. Compression therapy is the cornerstone of conservative treatment for chronic venous…

10. 5. 2023 Source: Wound Healing

Metamizole in Pain Management for Patients with Subarachnoid Hemorrhage

A study by Czech authors from the University Hospital St. Anna in Brno, recently published in the British Journal of Neurosurgery, evaluated analgesic treatment in patients with subarachnoid…

10. 5. 2023 Source: Analgesia

Comparison of the Effectiveness of Different Types of Toothbrushes in Orthodontic Patients

The aim of the study cited below was to evaluate the efficiency of a manual orthodontic brush, an electric toothbrush with an oscillating head, and a sonic toothbrush in controlling plaque,…

10. 5. 2023 Source: Dental Care

Efficacy and Safety of Ozanimod in the Treatment of Relapsing-Remitting MS

The sphingosine-1-phosphate receptor (S1PR) modulator ozanimod has recently been approved for the treatment of active relapsing-remitting multiple sclerosis (RRMS). We summarize the current knowledge…

9. 5. 2023 Source: Modulation of S1P in the Treatment of Autoimmune Diseases

Ozanimod Expands Treatment Options for Ulcerative Colitis in Adult Patients

As a review article published last year in the journal Drugs suggests, ozanimod is an effective and well-tolerated medication for adult patients with moderate to severe ulcerative colitis (UC), both…

9. 5. 2023 Source: Modulation of S1P in the Treatment of Autoimmune Diseases

Ozanimod in Induction and Maintenance Therapy for Ulcerative Colitis −⁠ True North Study Results

Ozanimod is a selective modulator of the sphingosine-1-phosphate receptor (S1PR) approved for the treatment of ulcerative colitis (UC) in adult patients. We summarize the results of the phase III…

9. 5. 2023 Source: Modulation of S1P in the Treatment of Autoimmune Diseases

1 … 28 29 30 31 32 … 115

Back Filter by speciality

Remove filters